Brooks Andrews is a Partner with EW Healthcare Partners, one of the largest and oldest investment firms dedicated exclusively to healthcare. Before joining EW, Brooks was an investor with Roark Capital and FFL Partners, and he began his career as an investment banker with Barclays Capital. Brooks serves as a director on the boards of EW’s investments in Xenex and BreatheAmerica, and as a board observer for Axogen and EyePoint Pharmaceuticals. Brooks holds BBA and MA degrees from the University of Georgia and an MBA from Stanford University.
Bjarne Bergheim is the President and Chief Executive Officer of Sonendo, Inc., recently named the 19th fastest growing private company in America according to Inc. Magazine. Bjarne has a passion for driving and leading innovative and transformative fast-growth companies. Prior to Sonendo, Bjarne was a member of the Fjord Ventures, LLC team, helping to grow portfolio companies. Bjarne graduated Cum Laude with a Bachelor of Science degree in Mechanical Engineering from the University of California, Irvine in 1997 and earned a Master of Science degree from the California Institute of Technology in 1998.
Olav Bergheim has over 30 years of experience in creating and managing life science companies. He is a founder of Sonendo, Inc., in addition to several other successful life science companies including Volcano Corporation, 3F Therapeutics (acquired by Medtronic), Glaukos Corporation, Lonestar Heart Inc., Prelude Corporation and Metronom Health, Inc. Mr. Bergheim is also the founder of Fjord Ventures LLC, a life science accelerator located in Laguna Hills, California, where Sonendo was created. Mr. Bergheim was the chairman of Vessix Vascular, Inc. (acquired by Boston Scientific). Prior to starting Fjord Ventures, he spent 10 years at Domain Associates as a company creator and general partner. Prior to Domain, Mr. Bergheim spent 18 years with Baxter Healthcare at US and international locations, where he held various leadership and operating roles. Mr. Bergheim was a Corporate VP of Baxter as well as President of Baxter Germany, President of Baxter’s Cardiovascular Group (now Edwards Life Sciences) and General Manager of the Nordic area.
Anthony Bihl (Tony) brings more than 35 years of experience in finance, operations and business unit leadership across the global medical device market. He was Chief Executive Officer of Bioventus LLC from December 2013 until his retirement in April 2020. He was Group President of American Medical Systems (AMS), a subsidiary of Endo Pharmaceuticals, from June 2011 through June 2012 and President & CEO and Director of AMS from April 2008 until Endo acquired the company in June 2011. He served as Chief Executive Officer of Siemens Medical Solutions’ Diagnostics from January to November 2007, and prior to that held various leadership roles in his six years in the Diagnostics Division of Bayer HealthCare from 2000 through 2006, including serving as President from 2004 to 2006. He began his career with 20+ years in finance and operations leadership at E.I Dupont. Mr. Bihl is currently Chairman of the Board of Directors of Spectral Medical, Inc., is a member of the Board of Directors of Meridian Bioscience Inc. and of Flowonix Medical Inc., and is a member of the Board of Directors of the Arthritis Foundation. He earned a BS in Business Administration from the Pennsylvania State University.
Alex Crisses is a Managing Director at General Atlantic and focuses on investments in the firm’s Technology sector. Alex leads the firm’s thematic sourcing program and co-heads its Emerging Growth Initiative across sector and geography. Before joining General Atlantic in 2016, Alex was a Managing Director at Insight Venture Partners where he focused on Software investments globally. Alex's current Board Affiliations include Benevity, Flipp, Pymetrics, Gympass, Seismic Software and JumpCloud. Alex was selected as one of GrowthCap's Top 25 Software Investors of 2019.
Cory A. Eaves is an Operating Partner and part of General Atlantic’s Operations Group, providing strategic support and advice to the firm’s investment teams and portfolio companies with a focus on technology, operations and digital transformation. Before joining General Atlantic in 2009, he was Executive Vice President, Chief Technology Officer and Chief Information Officer at Misys plc. Earlier in his career, he served as Chief Technology Officer of SSA Global, one of the world’s largest enterprise software providers and a former General Atlantic portfolio company. He holds a BS in electrical engineering from the University of Iowa and an MBA from Babson College, and is a graduate of the Harvard Business School’s Advanced Management Program. He currently serves as chairman of the board for the Marfan Foundation and advisor for NetHope.
Thomas Engels is a retired executive of 3M Corporation, having worked in various assignments spanning a 39-year career with the company, including 15 years in executive business management. Prior to retiring from 3M, he served as vice president for the 3M ESPE Dental Division for six years, where he led the division globally with a progressive strategy of new product innovation and acquisitions. Other executive management assignments for 3M included managing director of 3M’s Mexico subsidiary and vice president/general manager of the Medical Device Division. The majority of his career was spent in various R&D, manufacturing and business management assignments spanning a wide range of medical supply, medical device and dental businesses. He has held various board positions including with Minnesota-based Medical Alley, the Mexico American Chamber of Commerce and the Dental Trade Alliance. He is currently an active board member of the National Children’s Oral Health Foundation. Mr. Engels pursued undergraduate studies at St. John’s University in Minnesota, prior to transferring to the University of Minnesota’s Institute of Technology, where he received a Bachelor of Science degree in Mechanical Engineering.
Dan Even spent more than 30 years in progressive leadership roles with Sybron Dental Specialties, including president from 2006-2011. While under his leadership, Sybron surpassed $1 billion in revenue with a broad portfolio of successful platforms including orthodontics (Ormco), endodontics (Sybron Endo), implants (Implant Direct), surface disinfection (Metrex) and esthetic restorative products (Kerr). Mr. Even has led several technological advancements in the field of dentistry, both by leading strategic acquisition activity as well as organically cultivating and optimizing internal development teams. He is a member and past president of the National Children’s Oral Health Foundation, and a past board member and president of the Orthodontic Manufacturing Association, as well as the American Association of Orthodontics Foundation. He also served on the board of trustees for the American Association of Endodontists Foundation for six years, acting as treasurer for two years. Mr. Even earned his Master of Business Administration degree at California Polytechnic University, Pomona, and a Bachelor of Science degree in Economics from the University of California, Davis.
Chau Q. Khuong is Partner at OrbiMed Advisors and since 2003 has principally focused on venture capital investments. Over his investment career, Mr. Khuong has gained extensive experience in financing research and development of new medicines and therapeutic devices at all stages, across different drug modalities, and a range of disease areas from oncology to infectious diseases to ophthalmology. Prior to OrbiMed, he developed skills in start-up operations and business development at Veritas Medicine, Inc., and in basic immunology research at the Yale School of Medicine and Massachusetts General Hospital. Mr. Khuong holds a BS in molecular, cellular and developmental biology and MPH with concentration in infectious disease, both from Yale University.
Paul Madera is Managing Director of Meritech Capital Partners, a $3 Billion venture capital fund he co-founded in 1999. Over the years he has led Meritech’s investments into several notable tech companies including 2Wire, BlueArc, Facebook, IntraLase, Riverbed Technology, Salesforce.com and Yammer. Prior to Meritech, he was an investment banker with Montgomery Securities and Morgan Stanley, and he served in the US Air Force as an F-16 Instructor Pilot. He holds a BS from the US Air Force Academy, and an MBA from The Stanford Graduate School of Business.